This summary is focused on purified eicosapentaenoic acid (EPA) prescription drugs, such as Vascepa® and Epadel®, as well as EPA epidemiology. Prescription EPA is different from fish oil that can be bought

Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] . It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL.

Epadel and Vascepa are prescription products containing highly purified EPA ethyl esters. Epadel reduced cardiovascular events when added to statins in JELIS, has been associated with reduced atherosclerotic plaque, and has a long history of use in Japan with a favorable safety and tolerability profile.

Mochida is an integrated Japanese pharmaceutical company that developed and markets a prescription pure EPA drug product, Epadel, as a treatment for hyperlipidemia and arteriosclerosis obliterans in Japan. Mochida sponsored and successfully completed a cardiovascular outcomes trial with Epadel in Japan , JELIS.

Mochida) announced that Mochida submitted a New Drug Application to the China National Medical Products Administration (NMPA) for Epadel S (development code: MND-21), a highly purified eicosapentaenoic acid (EPA) ethyl ester formulation that is being jointly developed in China by Mochida and

Icosapent ethyl is a stable ethyl ester of the omega-3 fatty acid, eicosapentaenoic acid (EPA). The mechanisms of action contributing to reduction of cardiovascular events with icosapent ethyl are not completely understood.

epadel简介. epadel（通用名称：二十碳五烯酸乙酯）为持田制药开发的作为药品的高纯度epa制剂，在日本的适应症为高脂血症和改善闭塞性动脉硬化伴发的溃疡、疼痛及皮肤温度降低。

2023年9月19日 · Epadel is a polyunsaturated fatty acid, usually found in fish oils, that is used in many supplements. EPA can be used for lowering elevated triglycerides in those who are hyperglyceridemic. In addition, EPA may play a therapeutic role in patients with cystic fibrosis by reducing disease severity and may play a similar role in type 2 diabetics ...

Eicosapentaenoic acid (EPA) drugs are prescribed as branded (B: EPADEL®) or generic products but no data exist concerning the differences in treatment outcomes between these products. Methods and Results: We investigated the differences in the serum levels of EPA, docosahexaenoic acid (DHA) and

Certificate of Origin (CoO), Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of “EPADEL S Capsules 900” are available. *PIL and SmPC are written in Japanese.